Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

TNFA TNF Pharmaceuticals Inc

1,15

0,00 (0,00%)

Nach Börsenschluss

Zuletzt aktualisiert: 23:12:12

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

TNF Pharmaceuticals (NASDAQ:TNFA)
Historical Stock Chart
Von Dez 2024 bis Dez 2024

Click Here for more TNF Pharmaceuticals Charts.

TNF Pharmaceuticals (NASDAQ:TNFA)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more TNF Pharmaceuticals Charts.

News TNF Pharmaceuticals Inc

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs
Donnerstag 19 Dezember 2024 (2 Wochen vor) • Business Wire

Premarket Action Is Heating Up For This Biotech
Dienstag 10 Dezember 2024 (3 Wochen vor) • AllPennyStocks.com

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference
Montag 9 Dezember 2024 (3 Wochen vor) • Business Wire

Form 8-K - Current report
Dienstag 26 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Freitag 1 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Freitag 1 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 4 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
Mittwoch 2 Oktober 2024 (3 Monate vor) • Business Wire

Form 8-K - Current report
Montag 23 September 2024 (3 Monate vor) • Edgar (US Regulatory)

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline
Mittwoch 21 August 2024 (4 Monate vor) • Business Wire

Weitere TNF Pharmaceuticals Inc News-Artikel

Deutsche Telekom (QX)

Health Care Select Sector

Energy Select Sector SPDR

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen